Aller au contenu principal
Profil bibliographique

Amir Tayaranian Marvian

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

18Publications signalées
639Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Parkinson's Disease Mechanisms and TreatmentsAlzheimer's disease research and treatmentsGinkgo biloba and Cashew ApplicationsNanoparticle-Based Drug DeliveryNerve injury and regeneration

Les publications récentes

Accès ouvert 2024 article OpenAlex

Distinct regulation of Tau Monomer and aggregate uptake and intracellular accumulation in human neurons

Amir Tayaranian Marvian, Tabea Strauß, Qilin Tang, Benjamin J. Tuck et autres

BACKGROUND: The prion-like spreading of Tau pathology is the leading cause of disease progression in various tauopathies. A critical step in propagating pathologic Tau in the brain is the transport from the extracellular environment and accumulation inside naïve neurons. Current research indicates …

de, gb, dk (code pays fourni par la source)

16 citations Molecular Neurodegeneration
Accès ouvert 2020 article OpenAlex

The status of the terminal regions of α-synuclein in different forms of aggregates during fibrillization

Amir Tayaranian Marvian, Farhang Aliakbari, Hossein Mohammad‐Beigi, Zeinab Alsadat Ahmadi et autres

The α-synuclein (αSN) amyloid fibrillization process is known to be a crucial phenomenon associated with neuronal loss in various neurodegenerative diseases, most famously Parkinson's disease. The process involves different aggregated species and ultimately leads to formation of β-sheet rich fibrillar structures. Despite …

de, ir, dk, gb (code pays fourni par la source)

7 citations International Journal of Biological Macromolecules
Accès ouvert 2019 article OpenAlex

In vitro models of synucleinopathies: informing on molecular mechanisms and protective strategies

Amir Tayaranian Marvian, David J. Koss, Farhang Aliakbari, Dina Morshedi et autres

Alpha-synuclein (α-Syn) is a central player in Parkinson's disease (PD) and in a spectrum of neurodegenerative diseases collectively known as synucleinopathies. The protein was first associated with PD just over 20 years ago, when it was found to (i) be a major …

de, gb, ir (code pays fourni par la source)

37 citations Journal of Neurochemistry
Accès ouvert 2018 article OpenAlex

The potential of zwitterionic nanoliposomes against neurotoxic alpha-synuclein aggregates in Parkinson's Disease

Farhang Aliakbari, Hossein Mohammad‐Beigi, Nasrollah Rezaei‐Ghaleh, Stefan Becker et autres

The protein α-synuclein (αSN) aggregates to form fibrils in neuronal cells of Parkinson's patients. Here we report on the effect of neutral (zwitterionic) nanoliposomes (NLPs), supplemented with cholesterol (NLP-Chol) and decorated with PEG (NLP-Chol-PEG), on αSN aggregation and neurotoxicity. Both NLPs retard …

se, ir, de, au, us, gb, dk (code pays fourni par la source)

45 citations Nanoscale
Accès ouvert 2017 article OpenAlex

Neurotoxicity of pre-incubated alpha-synuclein with neutral nanoliposomes on PC12 and SHSY5Y cell lines

Farhang Aliakbari, Ali Akbar Shabani, Hassan Bardania, Hadieh Alsadat Eslampanah Seyedi et autres

Alpha-synuclein (α-Syn) is an abundant protein in the brain with high tendency to convert into toxic aggregated forms that are involved in neurons degeneration in Parkinson's patients (PD). The conversion of α-Syn toward toxic aggregates may associate with bio-membranes and the interaction …

ir, dk (code pays fourni par la source)

4 citations Scientia Iranica

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.